Александр Граница - Безумие ли? Как психиатры выставляют диагноз? [litres]

148. Poli, Roberto. (2010a). "The many aspects of anticipation." Foresight, 12 (3), 7-17.Poli, Roberto. (2010b).

149. Pompoli A, Furukawa TA, Imai H, Tajika A, Efthimiou O, Salanti G. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis. Cochrane Database Syst Rev. 2016;4:CD011004. [PubMed]

150. Post-War Research on Post-Traumatic Stress Disorder. Part II – 1989 onwards Krzysztof Rutkowski, Edyta Dembinska Psychiatr. Pol. ONLINE FIRST Nr 22 Published ahead of print 20 June, 2015

151. Pozza A, Andersson G, Dettore D. What does best evidence tell us about the efficacy of group cognitive-behavioral therapy for obsessive-compulsive disorder? Protocol for a systematic review and metaanalysis. Psychol Res Behav Manag. 2015;8:225–230. [PMC free article] [PubMed]

152. Pozza A, Andersson G, Dettore D. What does best evidence tell us about the efficacy of group cognitive-behavioral therapy for obsessive-compulsive disorder? Protocol for a systematic review and metaanalysis. Psychol Res Behav Manag. 2015;8:225–230. [PMC free article] [PubMed]

153. Prasko J, Grambal A, Kasalova P, et al. Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders. Neuropsychiatric Disease and Treatment. 2016;12:2659–2676. doi:10.2147/NDT.S118058.

154. Prasko J, Kamaradova D, Cakirpaloglu S, et al. Predicting the therapeutic response to intensive psychotherapeutic programs in patients with neurotic spectrum disorders. Act Nerv Super Rediviva. 2015;57(1–2):30–39.

155. Prasko J, Raszka M, Adamcova K, et al. Predicting the therapeutic response to cognitive behavioral therapy in patients with the pharmacoresistant obsessive-compulsive disorder. Neuroendocrinol Lett. 2009;30(5):615–623. [PubMed]

156. Prasko J, Raszka M, Adamcova K, et al. Predicting the therapeutic response to cognitive behavioral therapy in patients with the pharmacoresistant obsessive-compulsive disorder. Neuroendocrinol Lett. 2009;30(5):615–623. [PubMed]

157. R.PIutchik, RKeflemian and H.Coute. A structural theory of ego defenses and emotions-n: EJsard "Emotions hi personality and psychopathotogy". N.Y., 1979, p.229–257.

158. Racine NM, Pillai Riddell RR, Khan M, Calic M, Taddio A, Tablon P. Systematic Review: Predisposing, Precipitating, Perpetuating, and Present Factors Predicting Anticipatory Distress to Painful Medical Procedures in Children. Journal of Pediatric Psychology. 2016;41(2):159–181. doi:10.1093/jpepsy/jsv076.

159. Relation entre mécanismes de défense et alliance thérapeutique

160. Ressler K.J., Nemeroff C.B. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders // Depression and Anxiety. 2000. V. 12 (Suppl. 1). P. 2 – 19.

161. Rufer M, Held D, Cremer J, et al. Dissociation as a predictor of cognitive behavior therapy outcome in patients with obsessive-compulsive disorder. Psychother Psychosom. 2006;75:40–46.[PubMed]

162. Sadeghi R, Mokhber N, Mahmoudi LZ, Asgharipour N, Seyfi H. A systematic review and metaanalysis of controlled treatment trials of metacognitive therapy for anxiety disorders. J Res Med Sci. 2015;20(9):901–909. [PMC free article] [PubMed]

163. Salviati M, Bersani FS, Terlizzi S, et al. Tinnitus: clinical experience of the psychosomatic connection. Neuropsychiatric Disease and Treatment. 2014;10:267–275. doi:10.2147/NDT.S49425.

164. Santos T, Madeira N. Neuroticism: the elephant in the room. J. Depress. Anxiety 2014; 3(1): 145.

165. Schunck T, Erb G, Mathis A, Jacob N, Gilles C, et al. (2008) Test-retest reliability of a functional MRI anticipatory anxiety paradigm in healthy volunteers. J Magn Reson Imaging 27: 459–468 Available: http://www.ncbi.nlm.nih.gov/pubmed/18307211Accessed 3 March 2012.

166. Seligman, M.E.P., Railton, P., Baumeister, R.F., Sripada, C.: Navigating into the future or driven by the past. Perspect. Psychol. Sci. 8(2), 119–141 (2013)

167. Servaas MN, Geerligs L, Renken RJ, Marsman JBC, Ormel J, Riese H. et al. Connectomics and neuroticism: an altered functional network organization. Neuropsychopharmacology 2015; 40(2): 296–304.

168. Simmons A, Matthews SC, Stein MB, Paulus MP. Anticipation of emotionally aversive visual stimuli activates right insula. Neuroreport. 2004;15:2261–65

169. Smeijers L, van de Pas H, Nyklicek I, Notten PJ, Pedersen SS, Kop WJ. The independent association of anxiety with non-cardiac chest pain. Psychol. Health 2014; 29(3): 253–263.

170. Sobanski JA, Cyranka K, Rodzinski P, Klasa K, Rutkowski K, Dembinska E. et al. Are neurotic personality traits and neurotic symptoms intensity associated with suicidal thoughts reported by patients of a day hospital for neurotic disorders? Psychiatr. Pol. 2014 [E-pub ahead of print]; DOI: 10.12740/psychiatriapolska.pl/online-first/5.

171. Sobanski JA, Klasa K, Cyranka K, Mielimaka M, Dembinska E, Muldner-Nieckowski L. et al. Effectiveness of intensive psychotherapy in a day hospital evaluated with Neurotic Personality Inventory KON-2006. Psychiatr. Pol. 2014 [E-pub ahead of print]: DOI: 10.12740/psychiatriapolska.pl/online-first/6.

172. Sobanski JA, Klasa K, Mielimaka M, et al. The crossroads of gastroenterology and psychiatry – what benefits can psychiatry provide for the treatment of patients suffering from gastrointestinal symptoms. Przeglad Gastroenterologiczny. 2015;10(4):222–228. doi:10.5114/pg.2015.51213.

173. Solobutina, M. M. (2014). Probabilistic predicting in speech in distress and at the neurotic disorders. OnLine J. Biol. Sci., 14, 150–154.

174. Solobutina, M. M. (2015). Insights into Anticipation Capacity Development. Review of European Studies, 7, 5-17.

175. Stahl S.M. Stahl's essential psychopharmacology: neuroscientifi c basis and practical application. 3 nd ed. Cambridge University Press, 2008. 1117 p

176. Styla R. Differences in effectiveness of intensive treatment programmes for neurotic and personality disorders. Is it worth monitoring effectiveness of a therapeutic team? Psychiatr. Pol. 2014; 48(1): 157–171.

177. Sulle applicazioni cliniche della logoterapia: una rassegna sull’eredita di Victor Emil Frankl E. Girmenia, L. Andrissi, V. Tambone Clin Ter 2014; 165 (4):e330-335. doi: 10.7417/CT.2014.1751

178. Sun X, Ke M, Wang Z. Clinical features and pathophysiology of belching disorders. International Journal of Clinical and Experimental Medicine. 2015;8(11):21906-21914.

179. Tehrani N. Extraversion, neuroticism and secondary trauma in Internet child abuse investigators. Occupational Medicine (Oxford, England). 2016; 66(5):403–407. doi:10.1093/occmed/kqw004.

180. Thamotharan S, Hubbard M, Fields S. Delay discounting, but not disinhibition or inattention, partially mediates the effects of neuroticism on disordered eating in adolescents. Eating behaviors. 2015;18:91–96. doi:10.1016/j.eatbeh.2015.04.005.

181. Thiel N, Hertenstein E, Nissen C, Herbst N, Kulz AK, Voderholzer U. The effect of personality disorders on treatment outcomes in patients with obsessive-compulsive disorders. J Pers Disord. 2013;27(6):697–715. [PubMed]

182. Tversky A., Kahneman D. Judgement under uncertainty: Heuristics and biases // Sci. 1974. V. 185. N 4157. P. 1124–1131.

183. Tzschoppe J, Nees F, Banaschewski T, et al. Aversive Learning in Adolescents: Modulation by Amygdala—Prefrontal and Amygdala—Hippocampal Connectivity and Neuroticism. Neuropsychopharmacology. 2014;39(4):875–884. doi:10.1038/npp.2013.287.

184. Wojdylo K, Karlsson W, Baumann N. Do I feel ill because I crave for work or do I crave for work because I feel ill? A longitudinal analysis of work craving, selfregulation, and health. Journal of Behavioral Addictions. 2016;5(1):90–99. doi:10.1556/2006.5.2016.005.